AMGN34:BVMF
Amgen
93,24 BRL
0,00%
(0,00) 1D
11. nov., 17:53:48 GMT -3 · BRL
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za AMGN34 …
Odpri
92,38 BRL
Visoka
93,24 BRL
Nizka
91,47 BRL
Tržna kapitalizacija
253,21 mrd.
Povprečni promet
307,00
Promet
5,86 tis.
52-tedenski najvišji tečaj
94,72 BRL
52-tedenski najnižji tečaj
47,76 BRL
Št. izdanih delnic
540,91 mio.
Št. zaposlenih
32 tis.
Odpri
92,38 BRL
Visoka
93,24 BRL
Nizka
91,47 BRL
Tržna kapitalizacija
253,21 mrd.
Povprečni promet
307,00
Promet
5,86 tis.
52-tedenski najvišji tečaj
94,72 BRL
52-tedenski najnižji tečaj
47,76 BRL
Št. izdanih delnic
540,91 mio.
Št. zaposlenih
32 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
TradingView
·
pred 34 minutami
TScan Therapeutics Q3 revenue drops after Amgen collaboration ends
Yahoo Finance
·
pred 1 uro
45 ETFs Add to Amgen (AMGN) Holdings on Tuesday
CoinMarketCap
·
pred 14 urami
Amgen Inc tokenized stock (xStock) Price History and Historical Data
Investor's Business Daily
·
pred 15 urami
How Amgen, In A Buy Zone, Is Taking On Novartis With A First-Ever
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Vizitka: Amgen
Generalni direktorRobert A. Bradway
Št. zaposlenih31,5 tis.
Ustanovljeno1980
SedežThousand Oaks, Kalifornija, Združene države Amerike
SektorHealth Care
Panoga-
Spletno mestoamgen.com